Polymer Factory Sweden AB receives order of approx
Börskollen - Aktier, fonder och ekonominyheter

Börskollen

För dig med koll på börsen

Pressmeddelande

Polymer Factory Sweden AB receives order of approx. SEK 160,000 from global life science company

Polymer Factory today announces an order of significant size, as a global life science company has placed an order amounting to approximately SEK 160,000.

Purchasing products from Polymer Factory’s portfolio of dendritic nanomaterials, one of the world’s largest life science companies has placed an order of EUR 16,000, amounting to approximately SEK 160,000. The products purchased are customized and will be used by the customer for product development purposes, possibly leading to further business opportunities for the Company upon successful evaluation.

A single order of this size is significant to Polymer Factory at this stage in the company growth and building business relationships with companies of this magnitude is strategically important.

CEO Elin Mignérus comments:

“Our dendritic nanomaterial platform has unlimited potential in the life science sector, ranging from therapeutic to diagnostic applications. The fact is, since becoming a public Company, we have secured customized orders of significant size from two global life science companies. This foretells the demand and interest for our dendritic products among life science companies and underlines the quality and unique position of our Company. The Company’s goal is to help our customers succeed by leveraging the benefits of dendritic amplification, and we are always working to bring these collaborations into long-term relationships.”

About Polymer Factory

Polymer Factory was founded in 2006 at KTH Royal Institute of Technology and its Board of Directors have been essential in driving dendritic nanotechnology research to commercialization for almost 15 years – expertise that has been transferred to the Company’s products. Emerging from many years of cutting-edge research within the field, Polymer Factory today has, in the Company’s assessment, the world’s largest product portfolio of dendritic materials with customers ranging from Big Pharma, MedTech and BioTech companies, to research-intensive institutes and academic research groups. Polymer Factory has also used the Company’s vast knowledge and expertise to develop a patented calibration technology, named SpheriCal®, designed for Mass Spectrometry instruments.


This disclosure contains information that Polymer Factory is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 31-01-2022 12:56 CET.

Bifogade filer

Press release 31 Jan - Order of significant sizehttps://mb.cision.com/Main/20298/3495434/1527448.pdf

Nyheter om Polymer Factory

Läses av andra just nu

Om aktien Polymer Factory

Senaste nytt